Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

E. Kahn, Steven; M. Haffner, Steven; Heise, Mark; H. Herman, William; R. Holman, Rury; C. Jones, Nigel; G. Kravitz, Barbara; M. Lachin, John; O’Neill, Mark; Zinman, Bernard; Viberti, Giancarlo

doi:10.1056/nejmoa066224

Public

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Published in New England Journal of Medicine • Dec 4, 2006

Authors:

Steven E. Kahn

Steven M. Haffner

Mark Heise

Abstract

BACKGROUND: The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known. METHODS: We evaluated rosiglitazone, metformin, and glyburide as initial treatment for recently diagnosed type 2 diabet...

Subject

Medicine

Rosiglitazone

Metformin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!